Literature DB >> 18483658

[Severe lactic acidosis caused by propofol infusion: report of one case].

Carlos Romero P1, Mónica Morales R, Luisa Donaire R, Osvaldo Llanos V, Rodrigo Cornejo R, Ricardo Gálvez A, José Castro O.   

Abstract

Propofol infusion syndrome (PRIS) is a rare but potentially lethal complications. This disorder is triggered under unknown circumstances by a propofol infusion of more than 5 mg/kg/h for more than 48 h. PRIS is characterized by a multiorgan failure and rhabdomyolysis and is induced by a disturbance in mitochondrial long chain fatty acid oxidation. We report a 43 year-old woman who underwent brain surgery due to a vascular malformation. In the immediate postoperative period, she had an unexplained and severe lactic acidosis. During anaesthesia, she received a propofol infusion of 7 mg/kg/h that continued in the UCI at a rate of 3.5 mg/kg/h, for 8 hours more. The suspicion of PRIS motivated immediate discontinuation of propofol with rapid correction of lactic acidosis and full recovery of the patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483658     DOI: /S0034-98872008000100011

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  3 in total

1.  Temporary hyperlactataemia during partial hepatectomy: Report of two cases.

Authors:  Yi Zou; Jitong Liu; Yongqiong Liao; Wanmin Pei; Gaoyin Kong
Journal:  Int J Surg Case Rep       Date:  2014-12-11

2.  Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study.

Authors:  Russel J Roberts; Jeffrey F Barletta; Jeffrey J Fong; Greg Schumaker; Philip J Kuper; Stella Papadopoulos; Dinesh Yogaratnam; Elise Kendall; Renee Xamplas; Anthony T Gerlach; Paul M Szumita; Kevin E Anger; Paul A Arpino; Stacey A Voils; Philip Grgurich; Robin Ruthazer; John W Devlin
Journal:  Crit Care       Date:  2009-10-29       Impact factor: 9.097

Review 3.  Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports.

Authors:  Adéla Krajčová; Petr Waldauf; Michal Anděl; František Duška
Journal:  Crit Care       Date:  2015-11-12       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.